Merck KGaA - 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
XLO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Merck KGaA since 12/22/2023

Holdings reported by Merck KGaA for Xilio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 681K $565K $0.83 Oct 26, 2021 Indirect
Series B Preferred Stock 0 Oct 26, 2021 Indirect Common Stock
Series C Preferred Srock 0 Oct 26, 2021 Indirect Common Stock

Transactions reported by Merck KGaA for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.